Neogenomics Inc (NASDAQ:NEO)

13.00
Delayed Data
As of Jun 18
 -0.08 / -0.61%
Today’s Change
7.08
Today|||52-Week Range
13.25
+46.73%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 12.50, with a high estimate of 15.00 and a low estimate of 11.00. The median estimate represents a -3.85% decrease from the last price of 13.00.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.04
Sales
$66.4M
Reporting Date
Jul 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 7.14%
 
 
 
 
 
 
Growthannually 38.46%
 
 
 
 
 
 

Sales

Growthquarterly 4.68%
 
 
 
 
 
 
Growthannually 2.65%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.